Hypoparathyroidism Market Report 2026
Download Free Sample Buy Now
Hypoparathyroidism Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Hypoparathyroidism Market Report 2026

Global Outlook – By Treatment (Hormone Replacement Therapy, Adjunctive Therapies), By Type (Hormone Replacement Therapy, Calcium And Vitamin D Supplements, Emerging Therapies), By Route Of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By End User (Hospitals, Specialty Clinics, Homecare Settings) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Hypoparathyroidism Market Overview

• Hypoparathyroidism market size has reached to $1.03 billion in 2025

• Expected to grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%

• Growth Driver: Increasing Cases Of Thyroid Cancer Fueling The Growth Of The Market Due To Rise In Surgical Interventions And Postoperative Complications

• Market Trend: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Hypoparathyroidism Market?

Hypoparathyroidism is a rare endocrine disorder where the parathyroid glands produce insufficient amounts of parathyroid hormone (PTH), which leads to low calcium and high phosphorus levels in the blood. The primary purpose of parathyroid hormone (PTH) is to regulate and maintain stable levels of calcium and phosphorus, which are essential for nerve, muscle, and bone function. Hypoparathyroidism can result from surgical removal or damage to the parathyroid glands, autoimmune diseases, genetic conditions, or, rarely, idiopathic causes.

The main types of treatments in hypoparathyroidism are hormone replacement therapy and adjunctive therapies. Hormone replacement therapy (HRT) refers to the medical treatment in which hormones are given to replace or supplement those that the body is no longer producing sufficiently. These are used for various types, including hormone replacement therapy, calcium and vitamin d supplements and emerging therapies. The various route of administration include oral and parenteral that are distributed through hospital pharmacy, retail pharmacy and online pharmacy, serving various end users such as hospitals, specialty clinics and homecare settings.

Hypoparathyroidism Market Global Report 2026 Market Report bar graph

What Is The Hypoparathyroidism Market Size and Share 2026?

The hypoparathyroidism market size has grown strongly in recent years. It will grow from $1.03 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to thyroid surgery complications, calcium deficiency cases, rare disease awareness, hospital endocrine care, hormone replacement availability.

What Is The Hypoparathyroidism Market Growth Forecast?

The hypoparathyroidism market size is expected to see strong growth in the next few years. It will grow to $1.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to advancements in recombinant therapies, improved rare disease diagnosis, patient adherence programs, specialty clinic expansion, precision endocrinology adoption. Major trends in the forecast period include increased diagnosis of rare endocrine disorders, growing use of recombinant parathyroid hormones, expansion of long-term calcium management therapies, improved awareness of post-surgical complications, development of adjunctive supportive treatments.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Hypoparathyroidism Market Segmentation

1) By Treatment: Hormone Replacement Therapy, Adjunctive Therapies

2) By Type: Hormone Replacement Therapy, Calcium And Vitamin D Supplements, Emerging Therapies

3) By Route Of Administration: Oral, Parenteral

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

5) By End User: Hospitals, Specialty Clinics, Homecare Settings

Subsegments:

1) By Hormone Replacement Therapy: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues, Calcimimetics, Calcium And Vitamin D Supplements

2) By Adjunctive Therapies: Magnesium Supplements, Phosphate Binders, Other Supportive Therapies

What Is The Driver Of The Hypoparathyroidism Market?

The increasing cases of thyroid cancer are expected to propel the growth of the hypoparathyroidism market going forward. Thyroid cancer refers to a type of cancer where abnormal cells grow in the thyroid gland, often forming a lump in the neck. The increasing cases of thyroid cancer are due to advancements in diagnostic imaging technologies, as they enable early and more frequent detection of small, asymptomatic thyroid nodules. Thyroid cancer accelerates hypoparathyroidism by increasing the need for thyroid surgeries, which can inadvertently damage the parathyroid glands. This leads to calcium imbalance and chronic hormone deficiency, driving demand for long-term disease management solutions. For instance, in May 2024, according to the American Cancer Society, a US-based non-profit organization, the number of new thyroid cancer cases reached 44,020 in 2025, up from 43,720 in 2023. Therefore, the increasing cases of thyroid cancer are driving the growth of the hypoparathyroidism industry.

Key Players In The Global Hypoparathyroidism Market

Major companies operating in the hypoparathyroidism market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc , Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited , Lupin Limited, Torrent Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., BridgeBio Pharma Inc., Ascendis Pharma A/S, Extend Biosciences Inc., Entera Bio Ltd.

Global Hypoparathyroidism Market Trends and Insights

Major companies operating in the hypoparathyroidism market are focusing on developing technologically advanced products, such as transition technology-based products, to enhance treatment efficacy and improve patient outcomes. TransCon technology-based products are therapeutics developed using TransCon (Transient Conjugation) technology, a proprietary platform designed to optimize drug delivery. For instance, in January 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, launched YORVIPATH (palopegteriparatide), its second TransCon technology-based product, in Germany and Austria for the treatment of adults with chronic hypoparathyroidism. YORVIPATH is a once-daily prodrug of parathyroid hormone (PTH 1-34) designed to maintain physiological PTH levels over 24 hours, addressing the underlying hormone deficiency in chronic hypoparathyroidism.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Hypoparathyroidism Market?

In July 2024, AstraZeneca plc, a UK-based pharmaceutical company, acquired Amolyt Pharma SAS for an undisclosed amount. With this acquisition, AstraZeneca aims to strengthen its rare disease portfolio, particularly in the area of endocrine diseases, leveraging Amolyt Pharma’s innovative pipeline and clinical-stage therapies. Amolyt Pharma SAS is a France-based biotechnology company developing eneboparatide, a long-acting parathyroid hormone analog for treating hypoparathyroidism.

Regional Insights

North America was the largest region in the hypoparathyroidism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hypoparathyroidism Market?

The hypoparathyroidism market consists of revenues earned by entities by providing services such as diagnostic testing, patient monitoring, telemedicine consultations, and specialized care for chronic disease management and education. The market value includes the value of related goods sold by the service provider or included within the service offering. The hypoparathyroidism market also includes sales of phosphate binders, and medical devices or diagnostic kits used for monitoring calcium, phosphorus, and parathyroid Hormone levels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Hypoparathyroidism Market Report 2026?

The hypoparathyroidism market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hypoparathyroidism industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Hypoparathyroidism Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.12 billion
Revenue Forecast In 2035 $1.54 billion
Growth Rate CAGR of 8.6% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Type, Route Of Administration, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc , Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Hypoparathyroidism Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Hypoparathyroidism Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Hypoparathyroidism Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Hypoparathyroidism Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increased Diagnosis Of Rare Endocrine Disorders

4.2.2 Growing Use Of Recombinant Parathyroid Hormones

4.2.3 Expansion Of Long-Term Calcium Management Therapies

4.2.4 Improved Awareness Of Post-Surgical Complications

4.2.5 Development Of Adjunctive Supportive Treatments

5. Hypoparathyroidism Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Endocrinology Centers

5.4 Homecare Settings

5.5 Long-Term Care Facilities

6. Hypoparathyroidism Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hypoparathyroidism Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Hypoparathyroidism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Hypoparathyroidism Market Size, Comparisons And Growth Rate Analysis

7.3. Global Hypoparathyroidism Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Hypoparathyroidism Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hypoparathyroidism Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hypoparathyroidism Market Segmentation

9.1. Global Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hormone Replacement Therapy, Adjunctive Therapies

9.2. Global Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hormone Replacement Therapy, Calcium And Vitamin D Supplements, Emerging Therapies

9.3. Global Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral

9.4. Global Hypoparathyroidism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

9.5. Global Hypoparathyroidism Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare Settings

9.6. Global Hypoparathyroidism Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues, Calcimimetics, Calcium And Vitamin D Supplements

9.7. Global Hypoparathyroidism Market, Sub-Segmentation Of Adjunctive Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Magnesium Supplements, Phosphate Binders, Other Supportive Therapies

10. Hypoparathyroidism Market Regional And Country Analysis

10.1. Global Hypoparathyroidism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Hypoparathyroidism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hypoparathyroidism Market

11.1. Asia-Pacific Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hypoparathyroidism Market

12.1. China Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hypoparathyroidism Market

13.1. India Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hypoparathyroidism Market

14.1. Japan Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hypoparathyroidism Market

15.1. Australia Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hypoparathyroidism Market

16.1. Indonesia Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hypoparathyroidism Market

17.1. South Korea Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hypoparathyroidism Market

18.1. Taiwan Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hypoparathyroidism Market

19.1. South East Asia Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hypoparathyroidism Market

20.1. Western Europe Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hypoparathyroidism Market

21.1. UK Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hypoparathyroidism Market

22.1. Germany Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hypoparathyroidism Market

23.1. France Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hypoparathyroidism Market

24.1. Italy Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hypoparathyroidism Market

25.1. Spain Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hypoparathyroidism Market

26.1. Eastern Europe Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hypoparathyroidism Market

27.1. Russia Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hypoparathyroidism Market

28.1. North America Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hypoparathyroidism Market

29.1. USA Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hypoparathyroidism Market

30.1. Canada Hypoparathyroidism Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hypoparathyroidism Market

31.1. South America Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hypoparathyroidism Market

32.1. Brazil Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hypoparathyroidism Market

33.1. Middle East Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hypoparathyroidism Market

34.1. Africa Hypoparathyroidism Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Hypoparathyroidism Market, Segmentation By Treatment, Segmentation By Type, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hypoparathyroidism Market Regulatory and Investment Landscape

36. Hypoparathyroidism Market Competitive Landscape And Company Profiles

36.1. Hypoparathyroidism Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Hypoparathyroidism Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Hypoparathyroidism Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Hypoparathyroidism Market Other Major And Innovative Companies

Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Lupin Limited, Torrent Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., BridgeBio Pharma Inc., Ascendis Pharma A/S, Extend Biosciences Inc., Entera Bio Ltd.

38. Global Hypoparathyroidism Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hypoparathyroidism Market

40. Hypoparathyroidism Market High Potential Countries, Segments and Strategies

40.1 Hypoparathyroidism Market In 2030 - Countries Offering Most New Opportunities

40.2 Hypoparathyroidism Market In 2030 - Segments Offering Most New Opportunities

40.3 Hypoparathyroidism Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Hypoparathyroidism Market, Overview Of Key Products - Product Examples
  • Table 2: Global Hypoparathyroidism Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Hypoparathyroidism Market, Supply Chain Analysis
  • Table 4: Global Hypoparathyroidism Market, Major Raw Material Providers
  • Table 5: Global Hypoparathyroidism Market, Major Resource Providers
  • Table 6: Global Hypoparathyroidism Market, Major Manufacturers (Suppliers)
  • Table 7: Global Hypoparathyroidism Market, Major Distributors And Channel Partners
  • Table 8: Global Hypoparathyroidism Market, Key Technologies & Future Trends
  • Table 9: Global Hypoparathyroidism Market, Major Trends
  • Table 10: Global Hypoparathyroidism Market, Major End Users
  • Table 11: Global Hypoparathyroidism Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Hypoparathyroidism Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Hypoparathyroidism Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Hypoparathyroidism Market - TAM, US$ Billion, 2025
  • Table 15: Global Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Hypoparathyroidism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Hypoparathyroidism Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Hypoparathyroidism Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Hypoparathyroidism Market, Sub-Segmentation Of Adjunctive Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Hypoparathyroidism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Hypoparathyroidism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Global Hypoparathyroidism Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 97: Global Hypoparathyroidism Market - Company Scoring Matrix
  • Table 98: Pfizer Inc. Financial Performance
  • Table 99: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 100: Merck & Co Inc. Financial Performance
  • Table 101: AbbVie Inc. Financial Performance
  • Table 102: Sanofi S.A. Financial Performance
  • Table 103: Global Hypoparathyroidism Market, Competitive Benchmarking (In USD Billions)
  • Table 104: Global Hypoparathyroidism Market, Competitive Dashboard
  • Table 105: Global Hypoparathyroidism Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 106: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 107: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Hypoparathyroidism Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Hypoparathyroidism Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Hypoparathyroidism Market, Supply Chain Analysis
  • Figure 4: Global Hypoparathyroidism Market, Major Raw Material Providers
  • Figure 5: Global Hypoparathyroidism Market, Major Resource Providers
  • Figure 6: Global Hypoparathyroidism Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Hypoparathyroidism Market, Major Distributors And Channel Partners
  • Figure 8: Global Hypoparathyroidism Market, Key Technologies & Future Trends
  • Figure 9: Global Hypoparathyroidism Market, Major Trends
  • Figure 10: Global Hypoparathyroidism Market, Major End Users
  • Figure 11: Global Hypoparathyroidism Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Hypoparathyroidism Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Hypoparathyroidism Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Hypoparathyroidism Market - TAM, US$ Billion, 2025
  • Figure 15: Global Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Hypoparathyroidism Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Hypoparathyroidism Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Hypoparathyroidism Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Hypoparathyroidism Market, Sub-Segmentation Of Adjunctive Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Hypoparathyroidism Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Hypoparathyroidism Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Hypoparathyroidism Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Hypoparathyroidism Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Hypoparathyroidism Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Global Hypoparathyroidism Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 97: Global Hypoparathyroidism Market - Company Scoring Matrix
  • Figure 98: Pfizer Inc. Financial Performance
  • Figure 99: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 100: Merck & Co Inc. Financial Performance
  • Figure 101: AbbVie Inc. Financial Performance
  • Figure 102: Sanofi S.A. Financial Performance
  • Figure 103: Global Hypoparathyroidism Market, Competitive Benchmarking (In USD Billions)
  • Figure 104: Global Hypoparathyroidism Market, Competitive Dashboard
  • Figure 105: Global Hypoparathyroidism Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 106: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 107: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Hypoparathyroidism Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Homeopathy Market Report 2026 - Global Outlook – By Type (Dilutions, Tinctures, Biochemics, Ointments, Tablets, Other Types), By Source (Plants, Animals, Minerals), By Distribution Channel (Homeopathic Clinics, Retailers...

Thyroid Function Test Market Report 2026 - Global Outlook – By Test Type (Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4), Free Triiodothyronine (FT3), Free Thyroxine (FT4)), By Indication (Hypot...

Anti-Thyroid Drugs Market Report 2026 - Global Outlook – By Drug Type (Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)), By Route of Administration (Oral, Intravenous, Other Route O...

Menopausal Hot Flashes Market Report 2026 - Global Outlook – By Type (Hormonal Treatment, Non-Hormonal Treatment, Alternative Treatment), By Pipeline Analysis (Phase III Drugs, Phase I And II Drugs), By Distribution Chan...

Thyroid Cancer Drugs Market Report 2026 - Global Outlook – By Drug Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types),...

Thyroid Cancer Diagnostics Market Report 2026 - Global Outlook – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Types), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End...

Hormone Therapy Market Report 2026 - Global Outlook – By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route Of Administration (Oral, Parent...

Nuclear Medicine Market Report 2026 - Global Outlook – By Type (Diagnostic, Therapeutic), By Application (Cardiology, Lymphoma, Thyroid, Neurology, Oncology, Other Applications), By End-User (Hospitals And Clinics, Diagn...

Frequently Asked Questions

The Hypoparathyroidism market was valued at $1.03 billion in 2025, increased to $1.12 billion in 2026, and is projected to reach $1.54 billion by 2030.

The global Hypoparathyroidism market is expected to grow at a CAGR of 8.2% from 2026 to 2035 to reach $1.54 billion by 2035.

Some Key Players in the Hypoparathyroidism market Include, Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co Inc., AbbVie Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline plc , Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited , Lupin Limited, Torrent Pharmaceuticals Ltd., Eagle Pharmaceuticals Inc., BridgeBio Pharma Inc., Ascendis Pharma A/S, Extend Biosciences Inc., Entera Bio Ltd. .

Major trend in this market includes: Transcon Platform Enables Long-Acting Prodrugs For Sustained Hormone Release. For further insights on this market. request a sample here

North America was the largest region in the hypoparathyroidism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hypoparathyroidism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us